Plant-based enveloped Ara h 2 bioparticles display exceptional hypo-allergenicity

Autor: C. Castenmiller, M. Stigler, M. E. Kirpas, S. Versteeg, J. H. Akkerdaas, G. Pena‐Castellanos, B. R. Blokhuis, S. C. Dreskin, L. Auger, R. Desgagnés, C. Martel, L. Mirande, B. Morel, J. Roberge, V. Stordeur, G. Tropper, L. P. Vézina, V. Gomord, E. C. de Jong, F. Redegeld, W. G. Shreffler, L. Aglas, R. van Ree

Publikováno v: Clinical and experimental allergy. Wiley-Blackwell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9f7c384b74d134123a45917739b486
https://pure.amc.nl/en/publications/plantbased-enveloped-ara-h-2-bioparticles-display-exceptional-hypoallergenicity(46c04883-70a7-46b3-9653-7900ae63cadb).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Les avantages de la production d’allergènes moléculaires par les plantes

Autor: A.C. Fitchette, L. Faye, L.P. Vezina, V. Stordeur, Elizabeth D. Fixman, Brian J. Ward, V. Gomord, S. Viel, G. Tropper, Lorna Garnier

Publikováno v: Revue Française d'Allergologie. 58:291-292

Introduction Les nanotechnologies revolutionnent de nombreux aspects de la medecine moderne, y compris le diagnostic et la therapie. Il est maintenant bien demontre qu’un antigene presente sous une forme monomere soluble est un immunogene faible, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::383b702756fae54e6ce8694be89eb420
https://doi.org/10.1016/j.reval.2018.02.183

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacy.

Autor: de Taeye SW; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., Faye L; ANGANY Innovation, 1 voie de l'innovation, Pharmaparc II, Val de Reuil, France., Morel B; ANGANY Innovation, 1 voie de l'innovation, Pharmaparc II, Val de Reuil, France., Schriek AI; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., Umotoy JC; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., Yuan M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA., Kuzmina NA; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Galveston, Texas, USA., Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA., Zhu X; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA., Grünwald-Gruber C; BOKU Core Facility Mass Spectrometry, Universität für Bodenkultur Wien, Vienna, Austria., Poniman M; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., Burger JA; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., Caniels TG; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., Fitchette AC; ANGANY Innovation, 1 voie de l'innovation, Pharmaparc II, Val de Reuil, France., Desgagnés R; ANGANY Inc, Québec, Quebec, Canada., Stordeur V; ANGANY Innovation, 1 voie de l'innovation, Pharmaparc II, Val de Reuil, France., Mirande L; ANGANY Innovation, 1 voie de l'innovation, Pharmaparc II, Val de Reuil, France., Beauverger G; ANGANY Innovation, 1 voie de l'innovation, Pharmaparc II, Val de Reuil, France., de Bree G; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA., Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA., Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Galveston, Texas, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Sanders RW; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands.; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, USA., Vezina LP; ANGANY Inc, Québec, Quebec, Canada., Beaumont T; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., van Gils MJ; Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam institute for Immunology and Infectious Diseases, Infectious Diseases, Amsterdam, The Netherlands., Gomord V; ANGANY Innovation, 1 voie de l'innovation, Pharmaparc II, Val de Reuil, France.; ANGANY Inc, Québec, Quebec, Canada.

Publikováno v: Plant biotechnology journal [Plant Biotechnol J] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.